FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117156673> ?p ?o ?g. }

• W2117156673 endingPage "2183" @default.
• W2117156673 startingPage "2176" @default.
• W2117156673 abstract "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. ADMA is generated by protein methyltransferase (PRMT) and is metabolized mainly by dimethylarginine dimethylaminohydrolase (DDAH). ADMA levels are reported to increase in patients with chronic kidney disease (CKD), thereby playing a role in the pathogenesis of accelerated atherosclerosis in this population. However, the precise mechanism underlying ADMA accumulation in these patients is not fully understood. This study investigated the molecular mechanism for the elevation of ADMA levels in CKD, using a rat remnant kidney model that represents progressive CKD. After male Sprague-Dawley rats underwent baseline measurement of BP and renal function, 5/6 subtotal nephrectomy (5/6Nx) and 4/6 nephrectomy were performed. Plasma and urinary levels of ADMA and symmetric dimethylarginine, an inert isomer of ADMA, were measured by HPLC. Expression levels of PRMT genes and DDAH proteins were analyzed by semiquantitative reverse transcription–PCR and Western blotting, respectively. Plasma ADMA levels were elevated in the Nx groups in proportion to the degree of nephrectomy despite marked increases in renal clearance of ADMA. In contrast, renal clearance of symmetric dimethylarginine was decreased and its plasma levels were increased in the Nx groups. Furthermore, both liver and kidney gene expression of PRMT was increased, whereas DDAH protein expression was decreased in the 5/6Nx group. Plasma ADMA levels were correlated with systolic BP levels. Moreover, adenovirus-mediated DDAH gene transfer into the 5/6Nx rats prevented the elevation of BP levels, which was associated with the reduction of plasma and urinary ADMA levels. The results presented here suggest that decreased DDAH levels as well as increased PRMT gene expression could cause the elevation of plasma ADMA levels, thereby eliciting hypertension in CKD. Substitution of DDAH protein or enhancement of its activity may become a novel therapeutic strategy for the treatment of hypertension-related vascular injury in CKD." @default.
• W2117156673 created "2016-06-24" @default.
• W2117156673 creator A5014620453 @default.
• W2117156673 creator A5015204019 @default.
• W2117156673 creator A5030113532 @default.
• W2117156673 creator A5042961127 @default.
• W2117156673 creator A5045324322 @default.
• W2117156673 creator A5056498978 @default.
• W2117156673 creator A5060887563 @default.
• W2117156673 creator A5070628886 @default.
• W2117156673 creator A5078389940 @default.
• W2117156673 creator A5082234778 @default.
• W2117156673 creator A5084319945 @default.
• W2117156673 creator A5087363466 @default.
• W2117156673 date "2006-08-01" @default.
• W2117156673 modified "2023-10-04" @default.
• W2117156673 title "Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease" @default.
• W2117156673 cites W1583601846 @default.
• W2117156673 cites W1970798352 @default.
• W2117156673 cites W1973216563 @default.
• W2117156673 cites W1975041319 @default.
• W2117156673 cites W1977312076 @default.
• W2117156673 cites W1981268963 @default.
• W2117156673 cites W1992049725 @default.
• W2117156673 cites W1996978408 @default.
• W2117156673 cites W2000881220 @default.
• W2117156673 cites W2001038193 @default.
• W2117156673 cites W2021958247 @default.
• W2117156673 cites W2024746608 @default.
• W2117156673 cites W2037655806 @default.
• W2117156673 cites W2049397775 @default.
• W2117156673 cites W2055136499 @default.
• W2117156673 cites W2058127911 @default.
• W2117156673 cites W2058385357 @default.
• W2117156673 cites W2065374983 @default.
• W2117156673 cites W2065764145 @default.
• W2117156673 cites W2075563193 @default.
• W2117156673 cites W2076680300 @default.
• W2117156673 cites W2106478344 @default.
• W2117156673 cites W2107818859 @default.
• W2117156673 cites W2115421882 @default.
• W2117156673 cites W2119568492 @default.
• W2117156673 cites W2120785970 @default.
• W2117156673 cites W2123706039 @default.
• W2117156673 cites W2124279221 @default.
• W2117156673 cites W2129050578 @default.
• W2117156673 cites W2135369804 @default.
• W2117156673 cites W2148531805 @default.
• W2117156673 cites W2151296579 @default.
• W2117156673 cites W2151554519 @default.
• W2117156673 cites W2153110646 @default.
• W2117156673 cites W2153125904 @default.
• W2117156673 cites W2154388708 @default.
• W2117156673 cites W2166969544 @default.
• W2117156673 cites W2169896560 @default.
• W2117156673 cites W2415194500 @default.
• W2117156673 cites W2520733964 @default.
• W2117156673 doi "https://doi.org/10.1681/asn.2005121379" @default.
• W2117156673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16807406" @default.
• W2117156673 hasPublicationYear "2006" @default.
• W2117156673 type Work @default.
• W2117156673 sameAs 2117156673 @default.
• W2117156673 citedByCount "151" @default.
• W2117156673 countsByYear W21171566732012 @default.
• W2117156673 countsByYear W21171566732013 @default.
• W2117156673 countsByYear W21171566732014 @default.
• W2117156673 countsByYear W21171566732015 @default.
• W2117156673 countsByYear W21171566732016 @default.
• W2117156673 countsByYear W21171566732017 @default.
• W2117156673 countsByYear W21171566732018 @default.
• W2117156673 countsByYear W21171566732019 @default.
• W2117156673 countsByYear W21171566732020 @default.
• W2117156673 countsByYear W21171566732021 @default.
• W2117156673 countsByYear W21171566732022 @default.
• W2117156673 countsByYear W21171566732023 @default.
• W2117156673 crossrefType "journal-article" @default.
• W2117156673 hasAuthorship W2117156673A5014620453 @default.
• W2117156673 hasAuthorship W2117156673A5015204019 @default.
• W2117156673 hasAuthorship W2117156673A5030113532 @default.
• W2117156673 hasAuthorship W2117156673A5042961127 @default.
• W2117156673 hasAuthorship W2117156673A5045324322 @default.
• W2117156673 hasAuthorship W2117156673A5056498978 @default.
• W2117156673 hasAuthorship W2117156673A5060887563 @default.
• W2117156673 hasAuthorship W2117156673A5070628886 @default.
• W2117156673 hasAuthorship W2117156673A5078389940 @default.
• W2117156673 hasAuthorship W2117156673A5082234778 @default.
• W2117156673 hasAuthorship W2117156673A5084319945 @default.
• W2117156673 hasAuthorship W2117156673A5087363466 @default.
• W2117156673 hasBestOaLocation W21171566731 @default.
• W2117156673 hasConcept C126322002 @default.
• W2117156673 hasConcept C134018914 @default.
• W2117156673 hasConcept C159641895 @default.
• W2117156673 hasConcept C185592680 @default.
• W2117156673 hasConcept C2777468819 @default.
• W2117156673 hasConcept C2778653478 @default.
• W2117156673 hasConcept C2779877776 @default.
• W2117156673 hasConcept C2780091579 @default.
• W2117156673 hasConcept C2780227381 @default.

• next